(Q34991988)

5 August 2017

Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial (English)

1 reference

acute myocardial infarction

5 August 2017

1 reference

1 reference

Thuesen L

1

1 reference

5 August 2017

Jørgensen JR

2

1 reference

5 August 2017

Kvistgaard HJ

3

1 reference

5 August 2017

Sørensen JA

4

1 reference

5 August 2017

Vaeth M

5

1 reference

5 August 2017

Jensen EB

6

1 reference

5 August 2017

Jensen JJ

7

1 reference

5 August 2017

Hagerup L

8

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 April 1983

1 reference

5 August 2017

1 reference

5 August 2017

286

1 reference

5 August 2017

1107-1108

1 reference

5 August 2017

6371

1 reference

Effects of verapamil on infarct size following experimental coronary occlusion

5 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1547460

Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction

8 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1547460

Experimental infarction studies

8 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6404344

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A protective effect of verapamil on hypoxic heart muscle

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6404344

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMCID

1547460

1 reference

5 August 2017

1 reference